carbamates has been researched along with Allergic Encephalomyelitis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernal-Chico, A; Brown, JM; Cipriani, R; Cravatt, BF; Hsu, KL; Manterola, A; Mato, S; Matute, C; Moreno-Rodríguez, M; Pérez-Samartín, A; Rodríguez-Puertas, R; Ruiz, A | 1 |
| Azuma, M; Banik, NL; Beeson, C; Haque, A; Inoue, J; Smith, A; Trager, N; Wallace Iv, G | 1 |
| Rosenberger, TA | 1 |
| Ribeiro, R; Tanaka, M; Wen, J; Zhang, Y | 1 |
| Azuma, M; Banik, NL; Inoue, J; Ray, SK; Rohrer, B; Samantaray, S; Smith, AW; Wheless, L | 1 |
5 other study(ies) available for carbamates and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.
Topics: Animals; Benzoates; Biphenyl Compounds; Brain; Calcium; Carbamates; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation; Mice; Mitochondria; Molecular Targeted Therapy; Monoacylglycerol Lipases; N-Methylaspartate; Neural Conduction; Piperidines; Pyramidal Tracts; Receptor, Cannabinoid, CB1; Triazoles | 2018 |
Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.
Topics: Animals; Blotting, Western; Calpain; Carbamates; Cell Proliferation; Cell Separation; Cysteine Proteinase Inhibitors; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunohistochemistry; Immunomodulation; In Situ Nick-End Labeling; Male; Mice; Monocytes; Multiple Sclerosis; Nerve Degeneration; Real-Time Polymerase Chain Reaction; T-Lymphocytes, Helper-Inducer | 2014 |
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
Topics: Animals; Calpain; Carbamates; Cysteine Proteinase Inhibitors; Encephalomyelitis, Autoimmune, Experimental; Immunomodulation; Male; Multiple Sclerosis; Nerve Degeneration | 2014 |
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Carbamates; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Macrophages; Mice, Inbred C57BL; Mice, Knockout; Microglia; Monoacylglycerol Lipases; Myelin Sheath; Oligodendroglia; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spinal Cord | 2015 |
Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis.
Topics: Animals; Calpain; Carbamates; Cell Death; Electroretinography; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Gliosis; Male; Mice; Myelin Basic Protein; Neuroprotective Agents; Nystagmus, Optokinetic; Optic Neuritis; Photic Stimulation; Retinal Ganglion Cells; Visual Acuity | 2016 |